Vandortuzumab
Vandortuzumab is a CHO-expressed humanized antibody targeting STEAP1. Vandortuzumab has a huIgG1 type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 145.5 kDa. The isotype control for Vandortuzumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001) .
Product Specifications
Product Name Alternative
DSTP-3086S Antibody; RG-7450 Antibody
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/vandortuzumab.html
Purity
99.00
Molecular Weight
(145.5 kDa)
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
I7661-32B-Biotin 100 µL
Integrin alpha2, beta1 (Collagen Receptor, VLA2) (Azide Free) (Biotin)
Sign In for Pricing
View Details 
K0918707 1.0 µg DNA
GTF3C5 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details MBS7040946-01 0.02 mg
Recombinant Uncharacterized protein F56D1.2 (F56D1.2)
Sign In for Pricing
View Details MBS7040946-02 0.1 mg
Recombinant Uncharacterized protein F56D1.2 (F56D1.2)
Sign In for Pricing
View Details 
MBS7040946-03 5x 0.1 mg
Recombinant Uncharacterized protein F56D1.2 (F56D1.2)
Sign In for Pricing
View Details